Articles dans des revues avec comité de lecture (161)
  1. 86. Vanden Bossche, M., & Roumeguere, T. (2012). Signes, diagnostic et traitements des prostatites chroniques. Encyclopédie médico-chirurgicale. Urologie.
  2. 87. Alkhateeb, S., Neill, M., Bar-Moshe, S., Rhijn, B. V., Kakiashvili, D. M., Fleshner, N. E., Jewett, M. A., Petein, M., Schulman, C., Hanna, S., Bostrom, P. J., Roumeguere, T., Shariat, S. F., Rorive, S., & Zlotta, A. (2011). Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin. Urology Annals, 3(3), 119-126. doi:10.4103/0974-7796.84954
  3. 88. Roumeguere, T., Delree, P., Van Antwerpen, P., Rorive, S., Vanhamme, L., de Ryhove, L., Serteyn, D., Wespes, E., Vanhaerverbeek, M., & Zouaoui Boudjeltia, K. (2011). Intriguing location of myeloperoxidase in the prostate: A preliminary immunohistochemical study. The Prostate, 72(5), 507-513. doi:10.1002/pros.21452
  4. 89. Neuzillet, Y., Guy, L., Long, J.-A., Zini, L., Chevreau, C., Duclos, B., Escudier, B., Gimel, P., Joly, F., Lang, H., Mejean, A., Oudard, S., & Roumeguere, T. (2011). Cas cliniques de cancer du rein des JOUM 2010. Progrès en urologie, 21 Suppl 2, S27-S33. doi:10.1016/S1166-7087(11)70006-9
  5. 90. Henriet, B., & Roumeguere, T. (2011). Overview of Conservative Erectile Dysfunction Treatment. European urology, 6(1), 56-59.
  6. 91. Luce, S., De Breucker, S., Van Gossum, A., Demols, A., Mekinda Ngono, Z. L., Ena, G., Kentos, A., Nouwynck, C., Van Laethem, J.-L., Sokolow, Y., Simon, P., Roumeguere, T., Ghanooni, R., Bailly, B., Vervaet, C., Marchand, M., & Pepersack, T. (2011). Vulnerability scores amongst old cancer patients. Journal of geriatric oncology, 2(1), 26.
  7. 92. Luce, S., De Breucker, S., Van Gossum, A., Demols, A., Mekinda Ngono, Z. L., Ena, G., Kentos, A., Nouwynck, C., Van Laethem, J.-L., Sokolow, Y., Simon, P., Roumeguere, T., Ghanooni, R., Bailly, B., Vervaet, C., Marchand, M., & Pepersack, T. (2011). Correlates of vulnerability amongst old cancer patients. Journal of geriatric oncology, 2(1), 26.
  8. 93. JAYASWAL, A., Roumeguere, T., Broeders, E. N., Quackels, T., Rorive, S., Lemy, A., & Nortier, J. (2011). Tolerance and efficacy of intravesical BCG treatment in non muscle-invasive bladder carcinoma after renal transplantation. Journal of the American Society of Nephrology, 22.
  9. 94. Zlotta, A., Roumeguere, T., Kuk, C., Alkhateeb, S., Rorive, S., Lemy, A., van der Kwast, T. H., Fleshner, N. E., Jewett, M. A., Finelli, A., Schulman, C., Lotan, Y., Shariat, S. F., & Nortier, J. (2011). Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non–muscle-invasive bladder cancer. European urology, 59, 1026-1031. doi:10.1016/j.eururo.2011.03.027
  10. 95. Simon, P., Roumeguere, T., & Noël, J. C. (2010). Human papillomavirus infection in couples with female low-grade intraepithelial cervical lesion. European journal of obstetrics, gynecology, and reproductive biology, 153(1), 8-11. doi:10.1016/j.ejogrb.2010.05.024
  11. 96. Roumeguere, T., Zouaoui Boudjeltia, K., Babar, S., Nuyens, V., Rousseau, A., Van Antwerpen, P., Ducobu, J., Wespes, E., & Vanhaeverbeek, M. (2010). Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha. European urology, 57(3), 522-528. doi:10.1016/j.eururo.2009.01.030
  12. 97. Rossi, M., & Roumeguere, T. (2010). Silodosin in the treatment of benign prostatic hyperplasia. Drug Design, Development and Therapy, 4, 291-297. doi:10.2147/DDDT.S10428
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Suivant >>